全文获取类型
收费全文 | 2082篇 |
免费 | 105篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 134篇 |
妇产科学 | 82篇 |
基础医学 | 268篇 |
口腔科学 | 55篇 |
临床医学 | 115篇 |
内科学 | 394篇 |
皮肤病学 | 42篇 |
神经病学 | 90篇 |
特种医学 | 44篇 |
外科学 | 300篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 124篇 |
眼科学 | 47篇 |
药学 | 165篇 |
中国医学 | 3篇 |
肿瘤学 | 210篇 |
出版年
2023年 | 13篇 |
2022年 | 31篇 |
2021年 | 71篇 |
2020年 | 31篇 |
2019年 | 36篇 |
2018年 | 46篇 |
2017年 | 41篇 |
2016年 | 50篇 |
2015年 | 64篇 |
2014年 | 88篇 |
2013年 | 89篇 |
2012年 | 140篇 |
2011年 | 125篇 |
2010年 | 72篇 |
2009年 | 58篇 |
2008年 | 115篇 |
2007年 | 123篇 |
2006年 | 120篇 |
2005年 | 129篇 |
2004年 | 111篇 |
2003年 | 94篇 |
2002年 | 67篇 |
2001年 | 50篇 |
2000年 | 52篇 |
1999年 | 40篇 |
1998年 | 15篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 12篇 |
1994年 | 8篇 |
1993年 | 9篇 |
1992年 | 35篇 |
1991年 | 21篇 |
1990年 | 13篇 |
1989年 | 17篇 |
1988年 | 15篇 |
1987年 | 26篇 |
1986年 | 21篇 |
1985年 | 17篇 |
1984年 | 7篇 |
1983年 | 13篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1973年 | 8篇 |
1972年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有2193条查询结果,搜索用时 15 毫秒
21.
Pai Sudhakar M. Fettner Scott H. Hajian Gerald Cayen Mitchell N. Batra Vijay K. 《Pharmaceutical research》1996,13(9):1283-1290
Purpose. The objective of this work was to develop and validate blood sampling schemes for accurate AUC determination from a few samples (sparse sampling). This will enable AUC determination directly in toxicology studies, without the need to utilize a large number of animals.
Methods. Sparse sampling schemes were developed using plasma concentration-time (Cp-t) data in rats from toxicokinetic (TK) studies with the antiepileptic felbamate (F) and the antihistamine loratadine (L); Cp-t data at 13–16 time-points (N = 4 or 5 rats/time-point) were available for F, L and its active circulating metabolite descarboethoxyloratadine (DCL). AUCs were determined using the full profile and from 5 investigator designated time-points termed critical time-points. Using the bootstrap (re-sampling) technique, 1000 AUCs were computed by sampling (N = 2 rats/point, with replacement) from the 4 or 5 rats at each critical point. The data were subsequently modeled using PCNONLIN, and the parameters (ka, ke, and Vd) were perturbed by different degrees to simulate pharmacokinetic (PK) changes that may occur during a toxicology study due to enzyme induction/inhibition, etc. Finally, Monte Carlo simulations were performed with random noise (10 to 40%) applied to Cp-t and/or PK parameters to examine its impact on AUCs from sparse sampling.
Results. The 5 time-points with 2 rats/point accurately and precisely estimated the AUC for F, L and DCL; the deviation from the full profile was ~10%, with a precision (%CV) of ~15%. Further, altered kinetics and random noise had minimal impact on AUCs from sparse sampling.
Conclusions. Sparse sampling can accurately estimate AUCs and can be implemented in rodent toxicology studies to significantly reduce the number of animals for TK evaluations. The same principle is applicable to sparse sampling designs in other species used in safety assessments. 相似文献
22.
Kadambari Batra Gul Motwani P. C. Sagar 《Indian journal of otolaryngology and head and neck surgery》2004,56(2):91-95
During a six month period, one hundred patients presenting with the primary complaint of hoarseness, in the out- patients department of otolaryngology at Safdarjung Hospital New Delhi were taken up fot the study Fach patient after being subjected to a detailed history- taking and examination, including a Fibreoptic Laryngoscopy was then put into one of ten categories on the basis of the ultimate diagnosis Functional voice disorders, forming the largest category with 51%, included lesions such as vocal nodules and polyps, which are secondary to vocal abuse A detailed study of the various types of functional voice disorders along with factors such as male female ratio and associated contributory factors was done the efficacy of the Fibreoptic laryngoscope as a diagnostic tool was also assessed 相似文献
23.
E. J. Estlin L. Lashford S. Ablett L. Price R. Gowing A. Gholkar J. Kohler I. J. Lewis B. Morland C. R. Pinkerton M. C. Stevens M. Mott R. Stevens D. R. Newell D. Walker C. Dicks-Mireaux H. McDowell P. Reidenberg P. Statkevich A. Marco V. Batra M. Dugan A. D. Pearson 《British journal of cancer》1998,78(5):652-661
A phase I study of temozolomide administered orally once a day, on 5 consecutive days, between 500 and 1200 mg m(-2) per 28-day cycle was performed. Children were stratified according to prior craniospinal irradiation or nitrosourea therapy. Sixteen of 20 patients who had not received prior craniospinal irradiation or nitrosourea therapy were evaluable. Myelosuppression was dose limiting, with Common Toxicity Criteria (CTC) grade 4 thrombocytopenia occurring in one of six patients receiving 1000 mg m(-2) per cycle, and two of four patients treated at 1200 mg m(-2) per cycle. Therefore, the maximum-tolerated dose (MTD) was 1000 mg m(-2) per cycle. The MTD was not defined for children with prior craniospinal irradiation because of poor recruitment. Plasma pharmacokinetic analyses showed temozolomide to be rapidly absorbed and eliminated, with linear increases in peak plasma concentrations and systemic exposure with increasing dose. Responses (CR and PR) were seen in two out of five patients with high-grade astrocytomas, and one patient had stable disease. One of ten patients with diffuse intrinsic brain stem glioma achieved a long-term partial response, and a further two patients had stable disease. Therefore, the dose recommended for phase II studies in patients who have not received prior craniospinal irradiation or nitrosoureas is 1000 mg m(-2) per cycle. Further evaluation in diffuse intrinsic brain stem gliomas and other high-grade astrocytomas is warranted. 相似文献
24.
Thomas J Cook Shanya Edwards Charlene Gyemah Manoj Shah Indu Shah Tiziana Fox 《Journal of the American Pharmacists Association》2004,44(5):583-586
OBJECTIVE: To determine the weight variation and calculated dosing variability of tablet fragments upon splitting unscored cyclobenzaprine hydrochloride 10 mg tablets using two common tablet splitting devices. DESIGN: Comparative pharmaceutics study. SETTING: Pharmacy school laboratory. PARTICIPANTS: Not applicable. INTERVENTIONS: Unscored cyclobenzaprine hydrochloride 10 mg tablets from one generic manufacturer were split with a tablet splitter or a kitchen knife by a licensed pharmacist and two doctor of pharmacy students (n = 15 tablets for each method per participant). MAIN OUTCOME MEASURES: Fragment weights (FWs) were compared with the theoretical weights (TWs), which were calculated as one half of the mean weight of the tablets used in each part of the experiment; means, relative standard deviations (RSDs), and percentages of TW were also calculated. RESULTS: The mean weight before splitting the 45 tablets with the tablet splitter was 136.6 +/- 2.1 mg (TW = 68.3 mg). The mean FW after splitting was 67.9 +/- 7.9 mg. The RSD of 11.6% corresponded to a range of 69.4% to 130.2% of the TW and an estimated drug content of the split fragments between 3.47 mg and 6.51 mg. The mean weight before splitting the 45 tablets cut with a kitchen knife was 136.6 +/- 2.0 mg (TW = 68.3 mg). The mean FW was 68.0 +/- 15.7 mg with a RSD of 23.2%, corresponding to a range of 49.9% to 149.5% of the TW and an estimated drug content of the split fragments between 2.49 mg and 7.48 CONCLUSION: Tablet fragments obtained after splitting this generic cyclobenzaprine 10 mg product varied considerably in weight and estimated drug content. Accordingly, splitting cyclobenzaprine 10 mg tablets to achieve 5 mg doses could result in unpredictable dosing and therapeutic response. 相似文献
25.
Cord factor (a mycobacterial toxin) treatment of mice for 72 hr resulted in decreased activities of hepatic drug metabolizing enzymes. The toxin treated animals exhibited reduced levels of liver cytochrome P-450 and cytochrome b5, accompanied by significant lowering of NADPH-cytochrome c reductase and NADH-cytochrome b5 reductase activities. The hepatic activities of aminopyrine N-demethylase and aniline hydroxylase were diminished, while liver cytosolic glutathione S-transferase activity was inhibited in mice receiving the toxin. Earlier studies from this laboratory (J. K. Batra, Ph.D. Thesis, Delhi University, India, 1982) on the effects of experimental tuberculosis on hepatic drug metabolism revealed changes similar to the presently reported influence of cord factor on mouse liver microsomal monooxygenases. Thus, the action of cord factor (on hepatic drug metabolism) largely mimics the effects of tuberculosis infection. 相似文献
26.
27.
Vikash Jaiswal Sidra Naz Angela Ishak Nitya Batra Jon Quinonez Dattatreya Mukherjee Nishan Babu Pokhrel 《Clinical Case Reports》2022,10(5)
We present a case report of a 2‐year‐old boy who presented to a local hospital to evaluate vague abdominal symptoms of one‐month duration. The patient, therefore, had an open cystogastrostomy and drainage of the free abdominal fluid with minimal complications. He was monitored for several days after his surgery. 相似文献
28.
Batra V Syed Z Gill JN Coburn MA Adegboyega P Digiovanni J Mathis M Shi R Kleiner-Hancock HE 《Journal of experimental & clinical cancer research : CR》2012,31(1):57
ABSTRACT: The purpose of the current study was to determine whether a tropical ginger derived compound 1'-acetoxychavicol acetate (ACA), suppresses skin tumor promotion in K5.Stat3C mice. In a two-week study in which wild-type (WT) and K5.Stat3C mice were co-treated with either vehicle, ACA, galanga extract, or fluocinolone acetonide (FA) and tetradecanoyl phorbol acetate (TPA), only the galanga extract and FA suppressed TPA-induced skin hyperproliferation and wet weight. None of these agents were effective at suppressing pTyr705 Stat3 expression. However, ACA and FA showed promising inhibitory effects against skin tumorigenesis in K5.Stat3C mice. ACA also suppressed phospho-p65 NF-kappaB activation, suggesting a potential mechanism for its action. 相似文献
29.
30.